Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Persistent neurotoxicity of systemically administered interferon-alpha.

C A Meyers1, R S Scheibel, A D Forman

  • 1Department of Neuro-Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030.

Neurology
|May 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Close proximity to blast: No long-term or lasting effect on cognitive performance in service members with and without TBI during blast exposure.

Journal of the International Neuropsychological Society : JINS·2022
Same author

Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond.

Gynecologic oncology·2016
Same author

Tibetan sound meditation for cognitive dysfunction: results of a randomized controlled pilot trial.

Psycho-oncology·2013
Same author

A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor.

Journal of neuro-oncology·2011
Same author

Time for a new era in the evaluation of targeted therapies for patients with chronic myeloid leukemia: inclusion of quality of life and other patient-reported outcomes.

Critical reviews in oncology/hematology·2011
Same author

Regional CBF in chronic stable TBI treated with hyperbaric oxygen.

Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc·2005

Long-term interferon-alpha therapy can cause persistent neurotoxicity in cancer patients, leading to incapacitating cognitive symptoms. This interferon neurotoxicity may not be reversible in all cases.

Area of Science:

  • Neuroscience
  • Oncology
  • Pharmacology

Background:

  • Interferon-alpha (IFN-a) is a cytokine used in cancer treatment.
  • Neurotoxicity is a known side effect of IFN-a therapy.
  • The long-term effects of IFN-a neurotoxicity require further investigation.

Purpose of the Study:

  • To assess persistent neurotoxicity in cancer patients after interferon-alpha therapy.
  • To characterize the nature and severity of cognitive deficits.
  • To determine the reversibility of interferon-induced neurotoxicity.

Main Methods:

  • Retrospective analysis of fourteen cancer patients.
  • Neuropsychological testing to evaluate cognitive function.
  • Assessment of factors potentially contributing to neurotoxicity.

Related Experiment Videos

Main Results:

  • Persistent neurotoxicity was observed in all fourteen patients long after treatment cessation.
  • Cognitive symptoms, primarily mild to moderate, were incapacitating for daily work.
  • Neuropsychological deficits were consistent with frontal-subcortical dysfunction.
  • Follow-up assessments showed improvement in two patients and deterioration in two others.

Conclusions:

  • Interferon-alpha therapy can lead to persistent neurotoxicity in cancer patients.
  • The observed neurotoxicity impacts daily functioning and may be irreversible in some individuals.
  • Further research is needed to understand and manage long-term interferon-induced neurological effects.